Search for: "v. Classen Immunotherapies Inc"
Results 41 - 60
of 62
Sorted by Relevance
|
Sort by Date
27 Feb 2010, 3:23 pm
In fact, the earlier non-precedential 2008 per curiam decision in Classen Immunotherapies, Inc. v. [read post]
20 Jul 2010, 2:31 pm
Mayo Collaborative Services involves a treatment method and Classen Immunotherapies, Inc. v. [read post]
22 Mar 2012, 4:55 am
Cir. 2011); Classen Immunotherapies, Inc. v. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)… [read post]
7 Aug 2012, 11:45 pm
Instead, the patentee Momenta made the investment, did the research, and engineered the new method disclosed in the '886 patent.The Chief Judge states [the majority] "ignores the binding precedent of Classen Immunotherapies, Inc. v. [read post]
28 Mar 2012, 10:54 am
The Way Forward from Mayo Collaborative Services is through the Classen Immunotherapies Remand*The reasoning in Mayo Collaborative Services makes no patent law logical sense on numerous grounds, including disregarding an important paragraph in the Supreme Court’s 1981 case of Diamond v. [read post]
7 Aug 2012, 7:43 pm
§ 271(e)(1), particularly in light of the Court’s prior decision in Classen Immunotherapies v. [read post]
12 Dec 2011, 9:02 am
For example, in Classen Immunotherapies, Inc. v. [read post]
18 May 2012, 5:45 am
” See Ultramercial, p. 6; Classen Immunotherapies, Inc. v. [read post]
25 Aug 2010, 12:37 am
Mayo Collaborative Services, Classen Immunotherapies, Inc. v. [read post]
10 Sep 2011, 12:32 am
(Spicy IP) (Spicy IP) US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al / ????????????????????????? [read post]
3 Jun 2009, 7:41 pm
Related posts:Biotech Claims Need to be Tied to a “Particular Machine or Apparatus” In a nonprecedential opinion today, Classen Immunotherapies, Inc. v. [read post]
26 Aug 2009, 9:00 am
Supreme Court has decided to take up the...Biotech Claims Need to be Tied to a “Particular Machine or Apparatus” In a nonprecedential opinion today, Classen Immunotherapies, Inc. v. [read post]
31 Aug 2011, 11:34 am
Classen Immunotherapies, Inc. v. [read post]
27 Oct 2009, 7:19 pm
Supreme Court has decided to take up the...Wegner’s Top Ten Patent Cases in 2009 Hal Wegner, former Director of the Intellectual Property Law Program...Biotech Claims Need to be Tied to a “Particular Machine or Apparatus” In a nonprecedential opinion today, Classen Immunotherapies, Inc. v. [read post]
15 Dec 2010, 7:36 am
Both of those cases (Classen Immunotherapies, Inc. v. [read post]
19 Sep 2011, 3:17 am
(IPBiz) Deep thoughts by Chief Judge Rader: Classen Immunotherapies, Inc. v. [read post]
29 Sep 2010, 12:49 pm
Signature Financial Group, Inc. [read post]
10 Jan 2013, 12:03 pm
Northwest, Inc. v. [read post]
7 Sep 2011, 8:03 am
.” ~Jack Handey Chief Judge Rader, joined by Circuit Judge Newman, offered their own deep thoughts in a concurring opinion on Classen Immunotherapies, Inc. v. [read post]
